EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Intravenous adrenaline (epinephrine): its use in the critical care setting

Matthew Ralph Bright, Rahul Mudannayake, Jonathon Fanning

Postgraduate Medical Journal · 13.02.2026 · 102 (1205) · 290-296

DOI: 10.1093/postmj/qgaf234 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Postgraduate Medical Journal, online erschienen am 09.01.2026. Verfasst von Matthew Ralph Bright und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesia, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba, Brisbane, QLD 4102, Australia. Hauptthemen laut MEDLINE: Epinephrine, Critical Care, Vasoconstrictor Agents. Die Arbeit nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adrenaline (epinephrine) is an endogenous catecholamine with potent β₁-adrenergic, moderate β₂-, and α₁-adrenergic activity, widely used in resuscitation and critical care. At lower infusion rates, it increases cardiac output and decreases systemic vascular resistance. While at higher doses it will result in greater inotropy and peripheral vasoconstriction, with potential adverse effects such as arrhythmias, lactic acidosis, and ischemia. This review synthesises contemporary evidence surrounding adrenaline’s physiological and pharmacological profile, highlighting its role in cardiac arrest, perioperative medicine, sepsis, toxidromes, and specific contraindicated states. Clinical trials, including PARAMEDIC-2 and various observational registries, support adrenaline’s effectiveness in achieving return of spontaneous circulation but raise concerns regarding neurological outcomes. The timing and dosing of adrenaline administration, particularly in non-shockable rhythms and in-hospital cardiac arrests, appear critical to optimising survival. Specific scenarios, such as post-cardiac surgery, neurosurgery, tamponade, and paediatric sepsis, demand tailored approaches due to distinct haemodynamic and pharmacological considerations. Conversely, adrenaline use may be contraindicated or require modification in patients with hypertrophic cardiomyopathies, carcinoid syndrome, or catecholamine-sensitive conditions. Despite its ubiquitous role in acute care, ongoing research is needed to define optimal dosing strategies and identify patient subgroups most likely to benefit from its use. Thoughtful, context-specific administration of adrenaline is essential to balancing efficacy with risk across the spectrum of emergency and perioperative medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpinephrineCritical CareVasoconstrictor AgentsHumansHeart ArrestInfusions, IntravenousSepsis

Stichwörter der Autor:innen

adult anaesthesiaadult intensive & critical careanaesthesia in cardiologyanaestheticseducation and training

Substanzen

EpinephrineVasoconstrictor Agents

Autor:innen und Institutionen

  • Department of Anaesthesia, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba, Brisbane, QLD 4102, Australia.
  • Department of Anaesthesia and Perfusion, The Prince Charles Hospital, 627 Rode Rd, Chermside QLD 4032, Australia.

Zitieren

APA

Bright, M. R., Mudannayake, R., & Fanning, J. (2026). Intravenous adrenaline (epinephrine): its use in the critical care setting. Postgraduate Medical Journal, 102(1205), 290-296. https://doi.org/10.1093/postmj/qgaf234

Vancouver

Bright MR, Mudannayake R, Fanning J. Intravenous adrenaline (epinephrine): its use in the critical care setting. Postgraduate Medical Journal. 2026;102(1205):290-296. doi:10.1093/postmj/qgaf234

BibTeX
@article{Bright2026,
  author = {Bright, Matthew Ralph and Mudannayake, Rahul and Fanning, Jonathon},
  title = {Intravenous adrenaline (epinephrine): its use in the critical care setting},
  journal = {Postgraduate Medical Journal},
  year = {2026},
  volume = {102},
  number = {1205},
  pages = {290--296},
  doi = {10.1093/postmj/qgaf234}
}
Kostenlos starten →